<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02940444</url>
  </required_header>
  <id_info>
    <org_study_id>WCH-20160601</org_study_id>
    <nct_id>NCT02940444</nct_id>
  </id_info>
  <brief_title>Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery</brief_title>
  <official_title>Safety and Efficacy of Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thromboembolism is an important perioperative complication in major thoracic surgery, even
      though current guidelines have recommended postoperative administration of heparin or LMWH
      for thromboprophylaxis for those high-risk patients, there are still many cases of
      thromboembolism. Therefore, as the guideline itself writes, the investigators believe the
      rational of dose and timing of heparin in thoracic surgery are still not well established.
      Therefore, the investigators aimed to conduct this randomized controlled study to explore the
      safety and efficacy of preoperative Administration of Heparin as Thromboprophylaxis in Major
      Thoracic Surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative bleeding volume (ml)</measure>
    <time_frame>the bleeding volume (ml) during operation in the operation room for all patients</time_frame>
    <description>During the operation, the blood loss of each patient was collected and measured, and recorded by the investigators.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>chest tube drainage volume (ml)</measure>
    <time_frame>from postoperative day 1 to chest tube remove(usually on postoperative day 3 for lobectomy or thymectomy,on postoperative day 7 for esophagectomy )</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>thromboembolism occurence rate (%)</measure>
    <time_frame>within 30 days after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>APTT (s)</measure>
    <time_frame>on postoperative day 1 for both group</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PT(s)</measure>
    <time_frame>on postoperative day 1 for both group</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>INR</measure>
    <time_frame>on postoperative day 1 for both group</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>blood platlet count(/L)</measure>
    <time_frame>on postoperative day 1 for both group</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>chest tube drainage duration (days)</measure>
    <time_frame>from postoperative day 1 to chest tube remove(usually on postoperative day 3 for lobectomy or thymectomy,on postoperative day 7 for esophagectomy )</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PT(s)</measure>
    <time_frame>rightly upon hospital admission day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APTT(s)</measure>
    <time_frame>rightly upon hospital admission day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>INR</measure>
    <time_frame>rightly upon hospital admission day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood platlet count(/L)</measure>
    <time_frame>rightly upon hospital admission day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Thromboprophylaxis</condition>
  <condition>Thoracic Surgery</condition>
  <arm_group>
    <arm_group_label>case group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>start heparin sodium (5000IU, BID) upon admission, and continue until discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>start heparin sodium (5000 IU,BID) from postoperative day 1, and continue until discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Heparin</intervention_name>
    <arm_group_label>case group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-75 years old without any preoperative VTEs;

          -  patients undergoing major thoracic surgery (including lobectomy, esophagectomy, and
             thymectomy).

        Exclusion Criteria:

          -  patients with coagulation disorders: preoperative international normalized ratio (INR)
             &gt; 1.5, or blood platelet count &lt; 50x10^9/L;

          -  patients receiving any therapeutic anticoagulation preoperatively;

          -  patients with severe renal or liver dysfunction.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yi-Dan Lin, MD</last_name>
    <phone>+86 18980602136</phone>
    <email>hanyudeng@stu.scu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Han-Yu Deng, MD</last_name>
    <phone>+86 18200295920</phone>
    <email>907151184@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of thoracic surgery, west china hospital, sichuan university</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Han-Yu Deng, MD</last_name>
      <phone>+86 18200295920</phone>
      <email>907151184@qq.com</email>
    </contact>
    <investigator>
      <last_name>Yi-Dan Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2016</study_first_submitted>
  <study_first_submitted_qc>October 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2016</study_first_posted>
  <last_update_submitted>October 21, 2016</last_update_submitted>
  <last_update_submitted_qc>October 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Yi-Dan Lin</investigator_full_name>
    <investigator_title>proffessor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

